<SEC-DOCUMENT>0001144204-15-059348.txt : 20151113
<SEC-HEADER>0001144204-15-059348.hdr.sgml : 20151113
<ACCEPTANCE-DATETIME>20151014121651
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001144204-15-059348
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20151014

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Synthetic Biologics, Inc.
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133808303
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		617 DETROIT STREET, SUITE 100
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48104
		BUSINESS PHONE:		(734) 332-7800

	MAIL ADDRESS:	
		STREET 1:		155 GIBBS STREET
		STREET 2:		SUITE 412
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADEONA PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIPEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20061214

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SHEFFIELD PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19970730
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="image_001.gif" ALT="" STYLE="height: 196px; width: 335px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">October 14, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>VIA EDGAR</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">United States Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.25in; text-indent: 0in; text-align: justify">and
Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">100 F Street, NE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attention: Suzanne Hayes, Assistant Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>Re:</I></B></TD><TD STYLE="text-align: justify"><B><I>Synthetic Biologics, Inc.</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><B><I>Registration Statement
on Form S-3 </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><B><I>Filed October 7, 2015</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><B><I><U>File No. 333-207327&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;</U></I></B>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Ms. Hayes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Synthetic Biologics,
Inc. (the &ldquo;Company&rdquo;) hereby requests acceleration of the effective date of the above-referenced Registration Statement
so that it may become effective by <B>5:00 p.m.</B> Eastern Daylight Time on <B>October 15, 2015</B> or as soon thereafter as reasonably practicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In making this request,
the Company acknowledges that: (i) should the Securities and Exchange Commission or the staff, acting pursuant to delegated authority,
declare the filing effective, it will not foreclose the Commission from taking any action with respect to the filing; (ii) the
action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve
the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) the Company may
not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>SYNTHETIC BIOLOGICS, INC.</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 46%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Steven A. Shallcross</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Steven A. Shallcross, Chief Financial Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#=A3P'$ '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MC)9$SV,YP1<M(OA:3-<P?Y80Y)4F^"-Z009H:A-^$=$/L04?^Y SWB1E(%$
M%_ %$( +F( >6O=V641B_*!T(@-%K@55U;(0;#=FK98!<@(U!^5:*:!M3T!_
M0A4 Y)=$4O-4]\5_S#1\>].&PM,/-62&XH9^\Q95>_=:-=-!/,,S53@2":
M%Z !C/@%$?^15#KX,KPD$+R4 CG8)0E8$!<#-3=(B1_X/*OG27HF(*BV-3ZU
M?B3770$0:?4G )8#.-!4!8TWB[18BXW7@6%VB8NU4<LU$(ZD4P8B4D/" /\
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DW=JN_=JP'=NR/=NT7=NV?=NXG=NZO=N\W=N^_=O +1H! 0 [

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
